Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials.
| dc.contributor.author | Sarzotti-Kelsoe, Marcella | |
| dc.contributor.author | Cox, Josephine | |
| dc.contributor.author | Cleland, Naana | |
| dc.contributor.author | Denny, Thomas | |
| dc.contributor.author | Hural, John | |
| dc.contributor.author | Needham, Leila | |
| dc.contributor.author | Ozaki, Daniel | |
| dc.contributor.author | Rodriguez-Chavez, Isaac R | |
| dc.contributor.author | Stevens, Gwynneth | |
| dc.contributor.author | Stiles, Timothy | |
| dc.contributor.author | Tarragona-Fiol, Tony | |
| dc.contributor.author | Simkins, Anita | |
| dc.coverage.spatial | United States | |
| dc.date.accessioned | 2017-06-02T12:39:07Z | |
| dc.date.available | 2017-06-02T12:39:07Z | |
| dc.date.issued | 2009-05-26 | |
| dc.identifier | ||
| dc.identifier.eissn | 1549-1676 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Public Library of Science (PLoS) | |
| dc.relation.ispartof | PLoS Med | |
| dc.relation.isversionof | 10.1371/journal.pmed.1000067 | |
| dc.subject | Clinical Laboratory Techniques | |
| dc.subject | Clinical Trials, Phase I as Topic | |
| dc.subject | Clinical Trials, Phase II as Topic | |
| dc.subject | Clinical Trials, Phase III as Topic | |
| dc.subject | Humans | |
| dc.subject | Practice Guidelines as Topic | |
| dc.title | Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials. | |
| dc.type | Journal article | |
| duke.contributor.orcid | Sarzotti-Kelsoe, Marcella|0000-0001-7392-6072 | |
| pubs.author-url | ||
| pubs.begin-page | e1000067 | |
| pubs.issue | 5 | |
| pubs.organisational-group | Basic Science Departments | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Duke Human Vaccine Institute | |
| pubs.organisational-group | Immunology | |
| pubs.organisational-group | Institutes and Centers | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Medicine, Duke Human Vaccine Institute | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Surgery | |
| pubs.publication-status | Published | |
| pubs.volume | 6 |
Files
Original bundle
- Name:
- Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials.pdf
- Size:
- 91.37 KB
- Format:
- Adobe Portable Document Format